BlackRock Amends ICU Medical Stake, Files 13G/A on Jan 24
Ticker: ICUI · Form: SC 13G/A · Filed: Jan 24, 2024 · CIK: 883984
| Field | Detail |
|---|---|
| Company | Icu Medical Inc/De (ICUI) |
| Form Type | SC 13G/A |
| Filed Date | Jan 24, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock updated its passive stake in ICU Medical, filing an amended 13G/A.**
AI Summary
BlackRock Inc. filed an amended Schedule 13G/A on January 24, 2024, indicating its ownership stake in ICU Medical Inc./DE as of December 31, 2023. This filing, Amendment No. 16, updates previous disclosures about BlackRock's passive investment in ICU Medical's common stock. This matters to investors because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in confidence or investment strategy, potentially influencing other investors' perceptions of ICU Medical's stock.
Why It Matters
This filing shows BlackRock's updated passive ownership in ICU Medical, providing transparency on a significant institutional investor's position, which can influence market sentiment.
Risk Assessment
Risk Level: low — This is a routine disclosure of passive ownership by a large institutional investor, indicating no immediate high-risk actions.
Analyst Insight
Investors should note BlackRock's continued passive stake in ICU Medical, but this filing alone doesn't suggest a change in investment thesis. Further investigation into BlackRock's overall portfolio changes or ICU Medical's recent performance would be prudent.
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- ICU Medical Inc./DE (company) — the subject company whose securities are being reported
- January 24, 2024 (date) — the filing date of the SC 13G/A
- December 31, 2023 (date) — the date of the event which required the filing
- Amendment No. 16 (number) — the specific amendment number for this filing
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, as indicated by 'FORM TYPE: SC 13G/A' and 'SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 16)'.
Who is the reporting person in this filing?
The reporting person is BlackRock Inc., as stated under 'FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BlackRock Inc.' and '(1)Names of reporting persons. BlackRock, Inc.'.
What is the subject company whose securities are being reported?
The subject company is ICU MEDICAL INC/DE, as identified under 'SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE' and '(Name of Issuer) ICU MEDICAL INC'.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of ICU Medical Inc. is 44930G107, as listed under '(CUSIP Number) 44930G107'.
What was the 'Date of Event Which Requires Filing of this Statement'?
The date of the event which required the filing of this statement was December 31, 2023, as specified in the filing.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 24, 2024 regarding ICU MEDICAL INC/DE (ICUI).